Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The PART study, which is a feasibility study comparing partial ablation (PA) using HIFU and standard treatment, radical prostatectomy (RP), recruited its first two patients in the first week of February.

Both patients were recruited by Oxford, the first site in the study to be set up. The Trial Manager, Steffi, is now working hard to set up the other sites involved in the PART study so that the recruitment target of 100 men can be met.

Congratulations to the PART team at the Churchill on their hard work!